Andere talen Sharps Technology, Inc.

Aandelen

STSS

US82003F1012

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 07-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,2789 ^USD	-5,62%		-26,99%	-32,94%

30/05	Sharps Technology ondertekent een 5-jarige verkoopovereenkomst voor spuiten van $200 miljoen en een amendement op de koopovereenkomst voor activa om te beginnen met de productie van voorvulbare speciale copolymeer spuiten in de VS	CI
14/05	Sharps Technology, Inc. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit	05/06
Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.	31/05
Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.	30/05
Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S	30/05
Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured Syringes	28/05
Sharps Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Sharps Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems	07/03
Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia	21/02
Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia	21/02
Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems	16/02
Sharps Technology Planning to Collaborate with Roncadelle to Support Global Distribution and Sales of High Quality, Innovative, Safer Drug Delivery Systems	16/02
Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems	18/01
Sharps Technology Signs LoI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems	18/01
Sharps Technology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement	29-09-23
Sharps Technology, Inc. announced that it has received $2.827853 million in funding	29-09-23
Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals	28-09-23
Sharps Technology Launches $5.6 Million Registered Direct Offering	27-09-23
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules	27-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sharps Technology, Inc.

Aandelen

STSS

US82003F1012

Andere talen

Filters